Literature DB >> 25384332

In response to "Conclusive strategies for therapy and virotyping of Helicobacter pylori".

Ayesha Alvi.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25384332      PMCID: PMC4196353          DOI: 10.4103/1319-3767.141701

Source DB:  PubMed          Journal:  Saudi J Gastroenterol        ISSN: 1319-3767            Impact factor:   2.485


× No keyword cloud information.
Sir, We thank Mobarez et al.[1] for the keen reading and the comments they made to our paper published in the Saudi Journal of Gastroenterology.[2] With regard to the actual benefits of studying the association between virulence factors in Helicobacter pylori and antibiotic resistance patterns, first and foremost, given the relatively established geographical prevalence of certain strains harboring specific virulence markers, if an association can be established between these virulence factors and antibiotic resistance patterns this can be used to decide the antibiotic regimen thus minimizing the chance of further antibiotic resistance. Moreover, this will also help understand the mechanism by which these virulence markers induce antibiotic resistance; this will add beneficial knowledge in the domain of antibiotic resistance, which ultimately can be correlated with other mechanisms in different bacteria. As to the issue whether metronidazole and clarithromycin can really be prescribed in current therapeutic regimens in Saudi Arabia, we completely agree with the author that there must be a large-scale study to further validate this. Lastly, it should be noted that the dynamic and astonishing nature of H. pylori virulence calls for a more comprehensive and novel approach before drawing final conclusions.
  2 in total

Review 1.  Therapy of Helicobacter pylori: present medley and future prospective.

Authors:  Amin Talebi Bezmin Abadi
Journal:  Biomed Res Int       Date:  2014-04-01       Impact factor: 3.411

Review 2.  Epidemiology and pattern of antibiotic resistance in Helicobacter pylori: scenario from Saudi Arabia.

Authors:  Mohammed Rizwan; Nuzhath Fatima; Ayesha Alvi
Journal:  Saudi J Gastroenterol       Date:  2014 Jul-Aug       Impact factor: 2.485

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.